Initiation, Advancement, and Acute Complications of Parenteral Nutrition
27. Adamkin DH, Gelke KN, Andrews BF. Fat emulsions and hypertriglyceridemia. JPEN J Parenter Enteral Nutr. 1984;8(5):563-567. doi:10.1177/0148607184008005563
28. Chait A. Hypertriglyceridemia. Endocrinol Metab Clin North Am. 2022;51(3):539-555. doi:10 . 1016 / j . ecl . 2022 . 02 . 010
29. Anez-Bustillos L, Dao DT, Baker MA, Fell GL, Puder M, Gura KM. Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract. 2016;31(5):596-609. doi:10 . 1177 / 0884533616662996
30. Driscoll D. Pharmaceutical and clinical aspects of lipid emulsions. JPEN J Parenter Enteral Nutr. 2017;41(1):125-134. doi:10 . 1177 / 0148607116673187
31. Sacks G, Brown R, Collier P, Kudsk K. Failure of topical vegetable oils to prevent essential fatty acid deficiency in a critically ill patient receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 1994;18(3):274-277. doi:10 . 1177 / 0148607194018003274
32. Mateu-de Antonio J, Florit-Sureda M. New strategy to reduce hypertriglyceridemia during parenteral nutrition while maintaining energy intake. JPEN J Parenter Enteral Nutr. 2016;40(5):705-712. doi:10 . 1177 / 0148607114549253
33. Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2022;46(1):12-41. doi:10 . 1002 / jpen . 2267
34. Calder P. Lipids for intravenous nutrition in hospitalised adult patients: a multiple choice of options. Proc Nutr Soc. 2013;72(3):263-276. doi:10.1017/S0029665113001250
35. Lekka M, Liokatis S, Nathanail C, Galani V, Nakos G. The impact of intravenous fat emulsion administration in acute lung injury. Am J Respir Crit Care Med. 2004;169(5):638-644. doi:10 . 1164 / rccm . 200305 - 620OC
36. American Society for Parenteral and Enteral Nutrition. Lipid injectable emulsion safety recommendations for adult patients. 2021. Accessed August 7, 2024. https:// nutritioncare . org / aspen - lipid - injectable - emulsions - safety - recommendations
37. Kumpf VJ. Complications of parenteral nutrition. In: Chan L-N, ed. ASPEN Adult Nutrition Support Core Curriculum. 4th edition. American Society for Parenteral and Enteral Nutrition; 2025:467-486.
38. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17(7-8):632-637. doi:10 . 1016 / s0899 - 9007(01)00542 - 1
39. Owers E, Reeves A, Ko S, et al. Rates of adult acute inpatients documented as at risk of refeeding syndrome by dietitians. Clin Nutr. 2015;34(1):134-139. doi:10 . 1016 / j . clnu . 2014 . 02 . 003
40. Parli S, Ruf K, Magnuson B. Pathophysiology, treatment, and prevention of fluid and electrolyte abnormalities during refeeding syndrome. J Infus Nurs. 2014;37(3):197-202. doi:10 . 1097 / NAN . 0000000000000038
41. Walmsley R. Refeeding syndrome: screening, incidence, and treatment during parenteral nutrition. J Gastroenterol Hepatol. 2013;28(suppl 4):113-117. doi:10 . 1111 / jgh . 12345
42. Kerndt P, Naughton J, Driscoll C, Loxterkamp D. Fasting: the history, pathophysiology and complications. West J Med. 1982;137(5):379-399.
43. Chalela J, Lopez J. Medical management of hunger strikers. Nutr Clin Pract. 2013;28(1):128-135. doi:10 . 1177 / 0884533612462896
44. Solomon SM, Kirby DF. The refeeding syndrome: a review. JPEN J Parenter Enteral Nutr. 1990;14:90-97. doi:10 . 1177 / 014860719001400190
45. Matthews K, Owers E, Palmer M. Agreement between student dietitians’ identification of refeeding syndrome risk with refeeding guidelines, electrolytes, and other dietitians: a pilot study. J Hum Nutr Diet. 2015;28(6):697-704. doi:10 . 1111 / jhn . 12281
46. Treinen C, Lomelin D, Krause C, Goede M, Oleynikov D. Acute acalculous cholecystitis in the critically ill: risk factors and surgical strategies. Langenbecks Arch Surg. 2015;400(4):421-427. doi:10 . 1007 / s00423 - 014 - 1267 - 6
47. Gu M, Kim T, Song J, Nam Y, Lee J, Park J. Risk factors and therapeutic outcomes of acute acalculous cholecystitis. Digestion. 2014;90(2):75-80. doi:10 . 1159 / 000362444
71
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149
